The global Gingivitis Treatment Market is predicted to generate a market value of US$ 7 billion in 2023 and a market value of US$ 11.19 billion by 2033, with a CAGR of 4.8% from 2023 to 2033. In the historical period 2018 to 2022, the market for Gingivitis Therapy grew at a CAGR of 3.2%. This growth is attributed to several factors, including the rising prevalence of gingivitis, increasing awareness about oral health, and the development of advanced treatment options.
One of the key drivers of the gingivitis treatment market is the increasing prevalence of gingivitis worldwide. According to the World Health Organization, around 10% to 15% of adults aged 35 to 44 have severe periodontal disease, while 30% to 50% of adults over the age of 50 have some form of periodontal disease.
Get Full PDF Sample Copy of Latest Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16841
Another factor driving the growth of the gingivitis treatment market is the increasing awareness about oral health among people. As people become more aware of the importance of maintaining good oral hygiene, they are seeking out better treatment options for gum disease.
North America currently holds the largest share of the gingivitis treatment market, owing to the high prevalence of gum disease in the region and the presence of major players in the market. However, the Asia Pacific region is expected to witness significant growth in the coming years, owing to the rising awareness about oral health and the increasing prevalence of gingivitis in the region.
Key Takeaways from the Market Study
- From 2018 to 2022, the Gingivitis Treatment market grew at a CAGR of 3.2%.
- The global Gingivitis Treatment market is expected to grow with a 4.8% CAGR during 2023 to 2033.
- As of 2033, the Gingivitis Treatment Market is expected to reach US$ 11.19 Billion.
- According to the FMI analysis, the retail pharmacies segment accounts for the largest market share.
- North America is expected to possess 40% market share for the Gingivitis Treatment market.
- The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.
“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Gingivitis Treatment.” says an FMI analyst
Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions@ https://www.futuremarketinsights.com/ask-question/rep-gb-16841
Market Competition
Key players in the market include companies such as Fibrocell Sciences, Tolmar Inc., Eli Lilly & Company, Align Technology, Dentsply International, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Orapharma, Kaken Pharmaceutical, and Valeant Pharmaceuticals Int., along with healthcare providers and technology companies among other global players.
- In October 2022, it was announced that a rapid test for gum disease is being developed by researchers at the University of Birmingham. The probe, designed for use in point-of-care settings such as dental surgeries or pharmacies, is expected to aid in the early detection of heart or lung disease, type 2 diabetes, and rheumatoid arthritis. A new technique developed by Professor Tim Albrecht from the School of Chemistry and Dr Melissa Grant from the School of Dentistry at the University provides a swift and accurate assessment of gum disease using a sample of saliva, which can be collected in any healthcare setting.
The technique involves a specialized probe and detector that provide quantitative measurements of biomarkers indicating the presence and severity of gum disease. These biomarkers were validated and identified by the university’s Periodontal Research Group and published in the Journal of Clinical Periodontology earlier this year. The researchers have secured funding from the EPSRC Impact Acceleration Account to create a prototype of the device, which is expected to be launched within a year.
More Insights Available
North America is one of the largest gingivitis diagnostics and therapeutics market, primarily driven by the high prevalence of gingivitis and periodontitis in the region. The increasing awareness about oral health and the availability of advanced diagnostic and therapeutic options are also contributing to the growth of the market in this region.
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/16841
Key Segments Profiled in the Gingivitis Treatment Industry Survey
Drug Class:
- Veetids
- Erythrocin
- Minocycline
- Doxycycline
- Clindamycin
- Chlorhexidine
- Acetaminophen
- Ibuprofen
- Lidocaine
Route of Administration:
- Oral
- Topical
End-User:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
About the Healthcare Division at Future Market Insights
The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts.
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs